Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Joslin Stories

2013-06-22 16:20:18

BRIDGEWATER, N.J. and BOSTON, June 22, 2013 /PRNewswire/ -- Sanofi US collaborated with Joslin Diabetes Center on a successful, multicultural outreach pilot that was overseen and funded by Sanofi US with Joslin as its partner in providing clinical and behavioral educational materials and training based on their award-winning On the Road diabetes program. The pilot, which was implemented in four ethnically diverse cities across the United States, demonstrated a significant reduction in...

2012-09-25 02:28:30

ARLINGTON, Va., Sept. 25, 2012 /PRNewswire/ -- Joslin Diabetes Center, the world's preeminent diabetes research and clinical care organization, and WorldOne, the global leader in healthcare insights and intelligence, today released the results of their recent comparative outlook survey at Joslin's Diabetes Innovation 2012 conference. (Logo: http://photos.prnewswire.com/prnh/20120828/NE60200LOGO)(Logo: http://photos.prnewswire.com/prnh/20120328/NE77237LOGO) The twin survey effort...

2011-03-31 07:00:00

BOSTON, March 31, 2011 /PRNewswire/ -- Joslin Diabetes Center has appointed John L. Brooks, III, a well-known leader in the life sciences industry, as President and Chief Executive Officer. (Photo: http://photos.prnewswire.com/prnh/20110331/NE74636 ) "Having seen John in action and worked closely with him, I know he will bring exceptional talents and experience to the role of Joslin chief executive," said Ralph James, interim Chairman of the Board of Trustees. "He has been a very...

2010-01-29 14:00:00

New collaboration leverages Joslin's deep clinical and research expertise and dLife's community and lifestyle approach to managing diabetes. BOSTON, Jan. 29 /PRNewswire-USNewswire/ -- Joslin.org, the Internet site for Harvard-affiliated Joslin Diabetes Center, the world's preeminent diabetes research and clinical care organization, and dLife.com, the leading online community for people living with diabetes, today announced a new online partnership. dLife will host a resource page on its...

2005-07-14 17:10:00

BOSTON "” July 14, 2005 "” A multicenter international study chaired by a Joslin Diabetes Center investigator and reported in the July issue of the American Diabetes Association's journal Diabetes brings hopeful news to the 18 million people in the United States "” and millions more worldwide "” with type 1 or type 2 diabetes. Initial results of the Phase III clinical trial demonstrated that 32 milligrams per day of ruboxistaurin (RBX) was well tolerated and may reduce...

2005-06-11 15:42:16

BOSTON - Scientists at Joslin Diabetes Center have investigated PKC-beta - a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes - for more than two decades. Their latest research, to be presented June 11 at the American Diabetes Association's (ADA) 65th Scientific Sessions in San Diego, Calif., confirms the link between hyperglycemia (high blood glucose), overexpression of PKC-beta 2 and kidney disease. The poster is one of 89 presentations Joslin...